XML 107 R92.htm IDEA: XBRL DOCUMENT v3.22.0.1
COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details) - Contingent Consideration Liability - Level 3 - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Arkis | Accrued expenses and other current liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, Beginning of Period $ 3,415 $ 0
Transfers from long-term to current portion 276 3,415
Change in fair value of contingent consideration liabilities 0 0
Balance, End of Period 3,691 3,415
Arkis | Other Noncurrent Liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, Beginning of Period 11,746 14,210
Transfers from long-term to current portion (276) (3,415)
Change in fair value of contingent consideration liabilities (62) 951
Balance, End of Period 11,408 11,746
Derma Sciences | Other Noncurrent Liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, Beginning of Period 230 230
Transfers from long-term to current portion   0
Change in fair value of contingent consideration liabilities   0
Balance, End of Period 230 230
ACell | Other Noncurrent Liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, Beginning of Period 0  
Additions from acquisition of ACell 23,900  
Change in fair value of contingent consideration liabilities (2,100)  
Balance, End of Period $ 21,800 $ 0